Other
JUUL
JUUL is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes
NCT04053868
completednot_applicable
Assisting Smokers to Switch to a JUUL E-Cigarette by Devaluing Combustible Cigarettes
NCT04188197
completednot_applicable
Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failures
NCT03502200
completednot_applicable
Study to Evaluate Constituents in Exhaled Breath and Room Air From Use of E-vapor Products and Conventional Cigarettes
NCT03605641
Clinical Trials (4)
Showing 4 of 4 trials
NCT04053868Not Applicable
Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes
NCT04188197Not Applicable
Assisting Smokers to Switch to a JUUL E-Cigarette by Devaluing Combustible Cigarettes
NCT03502200Not Applicable
Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failures
NCT03605641Not Applicable
Study to Evaluate Constituents in Exhaled Breath and Room Air From Use of E-vapor Products and Conventional Cigarettes
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4